Sana Boudabbous1, Pauline Guillemin1, Orane Lorton1, Laura Gui-Levy1, Stephane Desgranges1, Xavier Montet1, Christoph D Becker1, Raymond Miralbell2, Thomas Zilli2, and Rares Salomir1
1Radiology, Geneva University Hospitals, Image guided Interventions Laboratory, Geneva, Switzerland, 2Radiation Oncology, Geneva University Hospitals, Geneva, Switzerland
Synopsis
Combination of hyperthermia with ionizing radiation is
strongly compelling, based on principles of classic radiobiology, molecular
biology, and tumor physiology. MR-guided focused ultrasound (MRgFUS) is a
“touch-less” approach already employed for ablative pain palliation of
symptomatic bone metastases (SBM). MRgFUS mild hyperthermia adjuvant to radiation
therapy has not been reported for SMB pain palliation. We optimized here the
geometry of MRgFUS sonication and the automatic temperature control during
steady-state long lasting hyperthermia using a realistic ex-vivo anatomic model
mimicking osteolytic bone tumors. The results demonstrated uniform spatio-temporal
heating, together with predictable and safe thermal condition of the cortical
bone.
Background
Metastatic disease of the bone is a common cause of
pain and other significant symptoms with a detrimental impact into quality of
life. Single-dose palliative external
beam radiation therapy is the preferred treatment option, however, complete
pain response is often suboptimal and retreatment is necessary in one third of
the patients. Combination of
hyperthermia with radiation is strongly compelling as it is based on principles
of classic radiobiology, molecular biology, and tumor physiology1-4. Ablative MR-guided
focused ultrasound (MRgFUS) yielding temperature range > 65°C is already
employed standalone for primary treatment of pain palliation for symptomatic bone
metastases (SBM) using ExAblate5,6 (Insightec) and Sonalleve7 (Profound) devices. The
response rate at 3 months is on the order of 64% with treatment-related adverse
events occurring approximately in half of cases. MRgFUS mild hyperthermia
adjuvant to radiation therapy has not been reported for pain palliation of SBM.
A typical treatment plan requires steady-state local hyperthermia during 30
to 60 minutes. The local geometry of osteolytic bone metastases and the
specific interaction of focused ultrasound with the osteal tissue may impare the
intra-operatory control of isotherms. Methods
Fresh ex-vivo lamb shanks (N=8) were prepared under degassed
water. After skin and muscle incision, the posterior tibial cortex was
perforated using cylinder or cone drills (diameter range 4–15 mm). The yellow marrow
was excavated via the cortical breakthrough. The short diameter of the cavity
ranged 7.6-15.5 mm and the long diameter ranged 9.2-18.4 mm. The medullar cavity
was filled with thermo-acoustic tissue-mimicking gel. The mixture is liquid above 50°C and sets as gel less than one minute after injection. The incision path was sealed with polymer suture. Targeting
was achieved with high resolution T1 3D MR images of 0.8mm isotropic voxel (Figure 1) inside a 3T
clinical scanner, using a receive only loop coil (11cm diameter). A fluoroptical
temperature sensor (0.9mm diameter) was inserted mid-depth in the cortical bone
opposite to the breakthrough site, as gold-standard safety monitor. The
sonication was produced by a phased-array randomized transducer (256 element,
f=1.031MHz, R=130mm, D=140mm). The site of cortical breakthrough was centered as precise as
possible on the FUS beam axis. In successive experiments, the focal point was
positioned 5mm ahead the cortical breakthrough site, co-planar with the site and finally 5 mm deep inside the medullar cavity. Standard PRFS thermometry using
a segmented GRE-EPI sequence with lipid signal suppression and Bo-drift
compensation was performed parallel and perpendicular to the bone axis (TE=10ms,
voxel size 1x1x4 mm, temporal resolution 1.6s). Prescribed hyperthermia was
defined as uniform +6°C temperature elevation within the tissue-mimicking gel
for 12 minutes. A predictive temperature controller was implemented, automatically
adjusting the FUS energy deposition. Two thermal sources were considered inside
the medullar cavity: 1) the direct absorption of FUS beam around the focal
point, and 2) the passive heat flow centripetally from the internal cortical
wall, that is heated itself by the post-focal FUS beam. The second mechanism
yields a temporal lag between the acoustic power command and the temperature
response. The temperature controller took into account the predicted asymptotic
level of temperature elevation, as determined from a sliding temporal window of
observation.Results
High resolution MR thermometry demonstrated that the
thermal build up inside the medullar cavity tends to approximately uniform
isotherms (Figure 2), as an effect of heat diffusion and circumferential
heating of the surrounding cortical bone. The optimal focal point positioning was co-planar with the cortical breakthrough, without measurable thermal risk to the exposed cortical
bone. Deeper positioning yielded preferential heating of the opposite cortex
wall while more proximal positioning yielded enhanced heating of the breakthrough edges.
The average steady-state temperature elevation in 14
procedures was 6.16+/-0.23°C (Figure 3). PRFS thermometry applied to a gel-filled voxel
inside the medullar cavity, chosen to be adjacent to the intra-cortical
fluoroptical sensor, was found to slightly overestimate the true temperature
elevation in the post focal cortical bone (mean deviation 0.75°C, min -0.5°C, max 1.7°C). A correlation plot is provided in Figure 4.Discussion
The temporal lag between
the acoustic source command and the intra-medullar temperature response
produces periodic oscillations of the controlled temperature whenever a classic
feedback algorithm, i.e. PID, is used, as we actually observed in preliminary
experiments. This effect is theoretically
explained using the Laplace-transform formalism. Our predictive controller suppressed
the fluctuations and demonstrated typical accuracy of 0.2°C clearly sufficient
for clinical application. While cortical bone is not directly accessible to MR
thermometry, PRFS temperature monitoring of adjacent tumoral tissue was a very
good substitute under the present conditions of heating. Acknowledgements
No acknowledgement found.References
1. Song CW,
Park H, Griffin RJ. Improvement of tumor oxygenation by mild hyperthermia.
Radiation research 2001;155:515-528.
2.
Raaphorst GP, Yang DP, Ng CE. Effect of protracted mild hyperthermia on
polymerase activity in a human melanoma cell line. International journal of
hyperthermia : the official journal of European Society for Hyperthermic
Oncology, North American Hyperthermia Group 1994;10:827-834.
3. Raaphorst
GP, Ng CE, Yang DP. Thermal radiosensitization and repair inhibition in human
melanoma cells: A comparison of survival and DNA double strand breaks.
International journal of hyperthermia : the official journal of European
Society for Hyperthermic Oncology, North American Hyperthermia Group
1999;15:17-27.
4. Rau B,
Gaestel M, Wust P, Stahl J, Mansmann U, Schlag PM, Benndorf R. Preoperative
treatment of rectal cancer with radiation, chemotherapy and hyperthermia:
Analysis of treatment efficacy and heat-shock response. Radiation research
1999;151:479-488.
5. Napoli
A, Anzidei M, Marincola BC, Brachetti G, Ciolina
F, Cartocci G, Marsecano C, Zaccagna F, Marchetti
L, Cortesi E, Catalano C. Primary pain palliation and local tumor
control in bone metastases treated with magnetic resonance-guided focused
ultrasound. Invest Radiol. 2013 Jun;48(6):351-8.
6. Hurwitz
MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice
D, Fennessy FM, Kuten A, Meyer JE, LeBlang SD, Roberts
A, Choi J, Larner JM, Napoli A, Turkevich VG, Inbar
Y, Tempany CM, Pfeffer RM. Magnetic resonance-guided focused
ultrasound for patients with painful bone metastases: phase III trial results.
J Natl Cancer Inst. 2014 Apr 23;106(5).
7. Merel
Huisman, Mie K Lam, Lambertus W Bartels, Robbert J Nijenhuis, Chrit T Moonen,
Floor M Knuttel, Helena M Verkooijen, Marco van Vulpen, Maurice A van den
Bosch. Feasibility of volumetric MRI-guided high intensity focused ultrasound
(MR-HIFU) for painful bonemetastases. J Ther
Ultrasound. 2014; 2: 16. Published online 2014 Oct
10. doi: 10.1186/2050-5736-2-16